1% Tirbanibulin Ointment for Actinic Keratoses on Upper Extremities: A Retrospective Case Review Study.
作者信息
Iglesias-Puzas Álvaro, Conde-Taboada Alberto, Campos-Muñoz Lucía, Sirgado-Martínez Ana, López-Bran Eduardo
机构信息
Dermatology Department, Hospital Universitario Clínico San Carlos, c/ Profesor Martín Lagos, s/n, ES-28040 Madrid, Spain.
出版信息
Acta Derm Venereol. 2023 Oct 24;103:adv15296. doi: 10.2340/actadv.v103.15296.
Abstract
摘要
相似文献
1
1% Tirbanibulin Ointment for Actinic Keratoses on Upper Extremities: A Retrospective Case Review Study.1%替拉瑞林软膏治疗上肢光化性角化病：一项回顾性病例研究
Acta Derm Venereol. 2023 Oct 24;103:adv15296. doi: 10.2340/actadv.v103.15296.
2
Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results.他扎罗汀乳膏 1%治疗光化性角化病的疗效观察：Ⅰ期和Ⅱ期临床结果
J Drugs Dermatol. 2020 Nov 1;19(11):1093-1100. doi: 10.36849/JDD.2020.5576.
3
Pharmacokinetics, Safety, and Tolerability of a Single 5-Day Treatment of Tirbanibulin Ointment 1% in 100 cm : A Phase 1 Maximal-Use Trial in Patients with Actinic Keratosis.替比嘧啶软膏 1%在 100cm²单次 5 天治疗的药代动力学、安全性和耐受性：日光性角化病患者最大使用剂量的 1 期试验。
Clin Pharmacol Drug Dev. 2024 Feb;13(2):208-218. doi: 10.1002/cpdd.1368. Epub 2024 Jan 7.
4
Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.三期临床试验研究替比嘧啶软膏治疗光化性角化病。
N Engl J Med. 2021 Feb 11;384(6):512-520. doi: 10.1056/NEJMoa2024040.
5
Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice.1%替拉替尼软膏治疗光化性角化病的有效性、安全性及满意度：一项真实临床实践中的前瞻性研究
Australas J Dermatol. 2023 Nov;64(4):560-564. doi: 10.1111/ajd.14151. Epub 2023 Sep 7.
6
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients.替比嘧啶 1%软膏治疗癌前病变的疗效和耐受性：250 例意大利真实世界多中心观察研究。
Int J Dermatol. 2024 Nov;63(11):1566-1574. doi: 10.1111/ijd.17168. Epub 2024 Apr 11.
7
Tirbanibulin: Topical Treatment for Actinic Keratosis.替比嘧啶：光化性角化病的局部治疗。
Clin Drug Investig. 2021 Sep;41(9):751-755. doi: 10.1007/s40261-021-01068-9. Epub 2021 Aug 5.
8
Tirbanibulin: A New Topical Therapy for Actinic Keratoses With a Novel Mechanism of Action and Improved Ease of Use.替拉替林：一种用于光化性角化病的新型局部治疗药物，具有全新作用机制且使用便利性得到改善。
Clin Pharmacol Drug Dev. 2021 Oct;10(10):1126-1129. doi: 10.1002/cpdd.1024.
9
1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses.1%替比嘧啶软膏治疗光化性角化病。
Ann Pharmacother. 2022 Apr;56(4):494-500. doi: 10.1177/10600280211031329. Epub 2021 Jul 23.
10
Tirbanibulin 1% Ointment for Actinic Keratosis: Results from a Real-Life Study.他扎罗汀 1% 乳膏治疗光化性角化病：真实世界研究结果。
Medicina (Kaunas). 2024 Jan 28;60(2):225. doi: 10.3390/medicina60020225.
引用本文的文献
1
Real-World Efficacy of Tirbanibulin in Actinic Keratosis Treatment: Expert Consensus and Clinical Insights.替拉瑞林治疗光化性角化病的真实世界疗效：专家共识与临床见解
Dermatol Pract Concept. 2025 Jul 31;15(3):5921. doi: 10.5826/dpc.1503a5921.
2
Field Cancerization Treatment with Tirbanibulin 1% Ointment: Results in Real-World Practice.使用1%替瑞布林软膏进行场癌化治疗：真实世界实践结果
Acta Derm Venereol. 2025 Jul 1;105:adv42927. doi: 10.2340/actadv.v105.42927.
3
Clinical and experimental aspects of tirbanibulin treatments.替尔泊肽治疗的临床与实验方面
Arch Dermatol Res. 2025 Mar 19;317(1):603. doi: 10.1007/s00403-025-04119-9.
4
Topical Pharmacological Treatment of Actinic Keratoses: Focus on Tirbanibulin 1% Ointment.光化性角化病的局部药物治疗：聚焦于1%替拉替林软膏
Dermatol Pract Concept. 2024 Jul 1;14(3 S1):e2024145S. doi: 10.5826/dpc.1403S1a145S.
本文引用的文献
1
Successful treatment of field cancerization on the dorsum of the hands with 1% tirbanibulin ointment.
Clin Exp Dermatol. 2023 Aug 25;48(9):1048-1050. doi: 10.1093/ced/llad171.
2
Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratosis.替拉瑞林：对其新型作用机制及其在光化性角化病治疗中的应用的综述。
Actas Dermosifiliogr. 2022 Jan;113(1):58-66. doi: 10.1016/j.ad.2021.07.006. Epub 2021 Aug 2.
3
1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses.1%替比嘧啶软膏治疗光化性角化病。
Ann Pharmacother. 2022 Apr;56(4):494-500. doi: 10.1177/10600280211031329. Epub 2021 Jul 23.
4
Red light photodynamic therapy with BF-200 ALA showed superior efficacy in the treatment of actinic keratosis on the extremities, trunk, and neck in a vehicle-controlled phase III study.在一项对照药物的 III 期临床研究中，BF-200 ALA 光动力疗法的红光治疗在治疗四肢、躯干和颈部的光化性角化病方面显示出更好的疗效。
J Am Acad Dermatol. 2021 Dec;85(6):1510-1519. doi: 10.1016/j.jaad.2021.03.031. Epub 2021 Mar 17.
5
Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results.他扎罗汀乳膏 1%治疗光化性角化病的疗效观察：Ⅰ期和Ⅱ期临床结果
J Drugs Dermatol. 2020 Nov 1;19(11):1093-1100. doi: 10.36849/JDD.2020.5576.
6
Comparison of Grenz ray and photodynamic therapy for field treatment of actinic keratoses on the forearm: A case series.前臂光化性角化病的光动力疗法与电灼术治疗的比较：一项病例系列研究。
Australas J Dermatol. 2021 Feb;62(1):64-68. doi: 10.1111/ajd.13439. Epub 2020 Oct 11.
7
Efficacy of aminolevulinic acid 20 % solution photodynamic therapy in the treatment of actinic keratoses on the upper extremities: A post hoc analysis of a phase 3, randomized, vehicle-controlled trial.
Photodiagnosis Photodyn Ther. 2020 Dec;32:102013. doi: 10.1016/j.pdpdt.2020.102013. Epub 2020 Sep 15.
8
A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper Extremities.一项针对上肢光化性角化病的氨基酮戊酸光动力疗法的随机、对照、3 期研究。
Dermatol Surg. 2019 Jul;45(7):890-897. doi: 10.1097/DSS.0000000000001760.
9
Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.0.5%秋水仙碱乳膏与 5-氨基酮戊酸光动力疗法治疗前臂光化性角化病和皮肤原位癌的疗效和安全性：一项随机对照试验。
Br J Dermatol. 2018 Nov;179(5):1081-1087. doi: 10.1111/bjd.16824. Epub 2018 Sep 25.
10
A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT).一项多中心、开放性、研究者发起的 IV 期临床试验，旨在评估 0.015%浓度的 Ingenol Mebutate 凝胶用于面部和头皮，以及 0.05%浓度的 Ingenol Mebutate 凝胶用于躯干和四肢治疗韩国光化性角化病患者的疗效和安全性（PERFECT）。
Br J Dermatol. 2018 Oct;179(4):836-843. doi: 10.1111/bjd.16368. Epub 2018 May 14.
Zotero 插件